Two Sigma Investments
LFCR icon

Two Sigma Investments’s Lifecore Biomedical LFCR Stock Holding History

Two Sigma Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,803
Closed -$227K – 4775
2025
Q4 		$227K Buy
+27,803
New +$206K ﹤0.01% 3714
2021
Q3 		– Sell
-22,757
Closed -$256K – 4498
2021
Q2 		$256K Sell
22,757
-18,708
-45% -$216K ﹤0.01% 3618
2021
Q1 		$440K Buy
+41,465
New +$466K ﹤0.01% 3050
2020
Q3 		– Sell
-37,936
Closed -$302K – 3342
2020
Q2 		$302K Buy
+37,936
New +$391K ﹤0.01% 2374
2020
Q1 		– Sell
-60,893
Closed -$689K – 3507
2019
Q4 		$689K Sell
60,893
-7,231
-11% -$76.9K ﹤0.01% 2536
2019
Q3 		$741K Sell
68,124
-14,898
-18% -$162K ﹤0.01% 2235
2019
Q2 		$778K Buy
83,022
+38,521
+87% +$389K ﹤0.01% 2164
2019
Q1 		$546K Buy
+44,501
New +$543K ﹤0.01% 2212
2018
Q4 		– Sell
-41,096
Closed -$592K – 3290
2018
Q3 		$592K Buy
+41,096
New +$568K ﹤0.01% 2334
2017
Q4 		– Sell
-12,935
Closed -$168K – 3289
2017
Q3 		$168K Sell
12,935
-38,989
-75% -$514K ﹤0.01% 2618
2017
Q2 		$771K Buy
+51,924
New +$723K ﹤0.01% 2061
2016
Q3 		– Sell
-33,226
Closed -$358K – 3250
2016
Q2 		$358K Buy
33,226
+14,639
+79% +$161K ﹤0.01% 2459
2016
Q1 		$195K Sell
18,587
-17,271
-48% -$190K ﹤0.01% 2597
2015
Q4 		$424K Buy
+35,858
New +$440K ﹤0.01% 2062
2015
Q3 		– Sell
-46,680
Closed -$674K – 2482
2015
Q2 		$674K Buy
+46,680
New +$674K ﹤0.01% 1925
2014
Q4 		– Sell
-39,800
Closed -$488K – 2308
2014
Q3 		$488K Buy
39,800
+17,431
+78% +$218K ﹤0.01% 1305
2014
Q2 		$279K Buy
22,369
+10,664
+91% +$126K ﹤0.01% 1866
2014
Q1 		$131K Sell
11,705
-66
-0.6% -$724 ﹤0.01% 1857
2013
Q4 		$142K Buy
+11,771
New +$141K ﹤0.01% 2051
2013
Q3 		– Sell
-45,758
Closed -$604K – 1982
2013
Q2 		$604K Buy
+45,758
New +$633K ﹤0.01% 1311

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments's LFCR Position: Q1 2026 in Review

Two Sigma Investments sold out of Lifecore Biomedical (LFCR) in Q1 2026, closing a stake of 27,803 shares — an estimated $227K sold.

Two Sigma Investments first reported a position in LFCR in Q2 2013 and held it in 20 quarters. The position peaked at $778K in Q2 2019. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Two Sigma Investments reported no remaining Lifecore Biomedical position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 27,803 Lifecore Biomedical shares in Q1 2026, an estimated $227K.
  • Two Sigma Investments first reported a position in Lifecore Biomedical in Q2 2013 and held it in 20 quarters.
  • Two Sigma Investments's Lifecore Biomedical position peaked at $778K in Q2 2019.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.